Plot options



2. Select dataset:

Survival options

Survival INFO
Split patients by
Auto select best cutoff INFO
Trichotomization:  INFO
Exclude samples with a protein expression of 0: INFO

Restrict analysis to subtypes...

ER status: (n=1126)
PGR status: (n=946)
HER2 status: (n=704)

Stage: (n=923)
Grade: (n=160)
Lymph node status: (n=1153)

T: (n=984)
N: (n=859)
M: (n=757)

Restrict analysis to selected cohorts...

Race: (n=930)
Menopausal status: (n=125)

Radiation therapy: (n=122)
Hormone therapy: (n=1111)
Chemotherapy: (n=999)

Compare datasets

METABRIC: long follow-up (median: 94 months), average characteristics (78% ER positive, 12% HER2 positive), treatment data available for this dataset only!
TCGA: very short follow-up (median only 25 months), no grade.
GSE40267: almost exclusively ER negative patients (92%).
GSE19783: nodal status not available, 38% ER negative, high proportion of HER2 positive patients (18%).

n = number of patients with available clinical data

Please note: the generated p value does not include correction for multiple hypothesis testing by default.

Please kindly cite our paper to support further development: Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1809 patients, Breast Cancer Res Treatment, 2010 Oct;123(3):725-31. Copyright © 2009-2020 | Contact | Sitemap